APA (7th ed.) Citation

Eslami, M., Mehrabi, M., Payandeh, M., & Saba, F. Polatuzumab vedotin combined with bendamustine and rituximab for relapsed/refractory diffuse large B-cell lymphoma: A systematic review protocol. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Eslami, Mohammadreza, Mahdi Mehrabi, Mehrdad Payandeh, and Fakhredin Saba. Polatuzumab Vedotin Combined with Bendamustine and Rituximab for Relapsed/refractory Diffuse Large B-cell Lymphoma: A Systematic Review Protocol. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Eslami, Mohammadreza, et al. Polatuzumab Vedotin Combined with Bendamustine and Rituximab for Relapsed/refractory Diffuse Large B-cell Lymphoma: A Systematic Review Protocol. Public Library of Science (PLoS).